71 related articles for article (PubMed ID: 28218045)
1. The significance of Trk receptors in pancreatic cancer.
Johnson MD; Stone B; Thibodeau BJ; Baschnagel AM; Galoforo S; Fortier LE; Ketelsen B; Ahmed S; Kelley Z; Hana A; Wilson TG; Robertson JM; Jury RP; Wilson GD
Tumour Biol; 2017 Feb; 39(2):1010428317692256. PubMed ID: 28218045
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer bears overexpression of neurotensin and neurotensin receptor subtype-1 and SR 48692 counteracts neurotensin induced cell proliferation in human pancreatic ductal carcinoma cell line PANC-1.
Wang JG; Li NN; Li HN; Cui L; Wang P
Neuropeptides; 2011 Apr; 45(2):151-6. PubMed ID: 21272935
[TBL] [Abstract][Full Text] [Related]
3. Rare ALK expression but no ALK rearrangement in pancreatic ductal adenocarcinoma and neuroendocrine tumors.
Graham RP; Oliveira AM; Zhang L
Pancreas; 2013 Aug; 42(6):949-51. PubMed ID: 23851431
[TBL] [Abstract][Full Text] [Related]
4. [Responses of pancreatic cancer cells to stimulations by nerve growth factor and the role of Trk-A expression].
Diao DM; Song YC; Hou N; Xu HF; Wang JG; Dang CX
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):296-300. PubMed ID: 22445970
[TBL] [Abstract][Full Text] [Related]
5. The neurotrophin-trk receptor axes are critical for the growth and progression of human prostatic carcinoma and pancreatic ductal adenocarcinoma xenografts in nude mice.
Miknyoczki SJ; Wan W; Chang H; Dobrzanski P; Ruggeri BA; Dionne CA; Buchkovich K
Clin Cancer Res; 2002 Jun; 8(6):1924-31. PubMed ID: 12060637
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer.
Wang OH; Azizian N; Guo M; Capello M; Deng D; Zang F; Fry J; Katz MH; Fleming JB; Lee JE; Wolff RA; Hanash S; Wang H; Maitra A
PLoS One; 2016; 11(3):e0152300. PubMed ID: 27023625
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of immunohistochemical RhoA expression on survival in pancreatic ductal adenocarcinoma: a high-throughput analysis.
Dittert DD; Kielisch C; Alldinger I; Zietz C; Meyer W; Dobrowolski F; Saeger HD; Baretton GB
Hum Pathol; 2008 Jul; 39(7):1002-10. PubMed ID: 18495213
[TBL] [Abstract][Full Text] [Related]
8. The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma.
Deng X; Ewton DZ; Li S; Naqvi A; Mercer SE; Landas S; Friedman E
Cancer Res; 2006 Apr; 66(8):4149-58. PubMed ID: 16618736
[TBL] [Abstract][Full Text] [Related]
9. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
10. High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma.
Huo Y; Yang M; Liu W; Yang J; Fu X; Liu D; Li J; Zhang J; Hua R; Sun Y
J Exp Clin Cancer Res; 2015 Aug; 34(1):88. PubMed ID: 26297342
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47.
Maitra A; Iacobuzio-Donahue C; Rahman A; Sohn TA; Argani P; Meyer R; Yeo CJ; Cameron JL; Goggins M; Kern SE; Ashfaq R; Hruban RH; Wilentz RE
Am J Clin Pathol; 2002 Jul; 118(1):52-9. PubMed ID: 12109856
[TBL] [Abstract][Full Text] [Related]
13. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
14. The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma.
Miknyoczki SJ; Chang H; Klein-Szanto A; Dionne CA; Ruggeri BA
Clin Cancer Res; 1999 Aug; 5(8):2205-12. PubMed ID: 10473107
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma.
Lehnen NC; von Mässenhausen A; Kalthoff H; Zhou H; Glowka T; Schütte U; Höller T; Riesner K; Boehm D; Merkelbach-Bruse S; Kirfel J; Perner S; Gütgemann I
Histopathology; 2013 Aug; 63(2):157-66. PubMed ID: 23808822
[TBL] [Abstract][Full Text] [Related]
16. Prolonged survival in pancreatic cancer patients with increased regucalcin gene expression: Overexpression of regucalcin suppresses the proliferation in human pancreatic cancer MIA PaCa-2 cells in vitro.
Yamaguchi M; Osuka S; Weitzmann MN; El-Rayes BF; Shoji M; Murata T
Int J Oncol; 2016 May; 48(5):1955-64. PubMed ID: 26935290
[TBL] [Abstract][Full Text] [Related]
17. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
18. Gene expression analysis of pancreatic cell lines reveals genes overexpressed in pancreatic cancer.
Alldinger I; Dittert D; Peiper M; Fusco A; Chiappetta G; Staub E; Lohr M; Jesnowski R; Baretton G; Ockert D; Saeger HD; Grützmann R; Pilarsky C
Pancreatology; 2005; 5(4-5):370-9. PubMed ID: 15983444
[TBL] [Abstract][Full Text] [Related]
19. The expression pattern of PDX-1, SHH, Patched and Gli-1 is associated with pathological and clinical features in human pancreatic cancer.
Quint K; Stintzing S; Alinger B; Hauser-Kronberger C; Dietze O; Gahr S; Hahn EG; Ocker M; Neureiter D
Pancreatology; 2009; 9(1-2):116-26. PubMed ID: 19077462
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]